Clinical real-world results of switching treatment from ranibizumab to aflibercept in patients with diabetic macular oedema

被引:0
作者
V E Konidaris
K T Tsaousis
Z Al-Hubeshy
K Pieri
J Deane
T Empeslidis
机构
[1] Leicester Royal Infirmary,Ophthalmology Department
来源
Eye | 2017年 / 31卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1629 / 1630
页数:1
相关论文
共 12 条
[1]  
Lim LS(2015)Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab Clin Ophthalmol 9 1715-1718
[2]  
Ng WY(2015)Short-term outcomes of aflibercept therapy for diabetic macular edema in patients with incomplete response to ranibizumab and/or bevacizumab Ophthalmic Surg Lasers Imaging Retina 46 950-954
[3]  
Mathur R(2016)Aflibercept for diabetic macular edema in eyes previously treated with ranibizumab and/or bevacizumab may further improve macular thickness Ophthalmic Surg Lasers Imaging Retina 47 836-839
[4]  
Wong D(undefined)undefined undefined undefined undefined-undefined
[5]  
Wong EY(undefined)undefined undefined undefined undefined-undefined
[6]  
Yeo I(undefined)undefined undefined undefined undefined-undefined
[7]  
Wood EH(undefined)undefined undefined undefined undefined-undefined
[8]  
Karth PA(undefined)undefined undefined undefined undefined-undefined
[9]  
Moshfeghi DM(undefined)undefined undefined undefined undefined-undefined
[10]  
Leng T(undefined)undefined undefined undefined undefined-undefined